Comparison of Nebivolol Monotherapy Versus Nebivolol in Combination With Other Antihypertensive Therapies for the Treatment of Hypertension
Nebivolol is a novel, β1 -adrenergic receptor blocker with vasodilatory properties mediated through the activation of the l -arginine/nitric oxide pathway. Short-term randomized clinical trials have demonstrated that nebivolol has antihypertensive efficacy benefits comparable to other β blockers but...
Gespeichert in:
Veröffentlicht in: | The American journal of cardiology 2009-01, Vol.103 (2), p.273-278 |
---|---|
1. Verfasser: | |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Schreiben Sie den ersten Kommentar!